Influence of PEGDA Molecular Weight and Concentration on the In Vitro Release of the Model Protein BSA–FITC from Photo Crosslinked Systems
Novel 3D printing techniques enable the development of medical devices with drug delivery systems that are tailored to the patient in terms of scaffold shape and the desired pharmaceutically active substance release. Gentle curing methods such as photopolymerization are also relevant for the incorpo...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/4/1039 |
_version_ | 1797603911843971072 |
---|---|
author | Natalia Rekowska Katharina Wulf Daniela Koper Volkmar Senz Hermann Seitz Niels Grabow Michael Teske |
author_facet | Natalia Rekowska Katharina Wulf Daniela Koper Volkmar Senz Hermann Seitz Niels Grabow Michael Teske |
author_sort | Natalia Rekowska |
collection | DOAJ |
description | Novel 3D printing techniques enable the development of medical devices with drug delivery systems that are tailored to the patient in terms of scaffold shape and the desired pharmaceutically active substance release. Gentle curing methods such as photopolymerization are also relevant for the incorporation of potent and sensitive drugs including proteins. However, retaining the pharmaceutical functions of proteins remains challenging due to the possible crosslinking between the functional groups of proteins, and the used photopolymers such as acrylates. In this work, the in vitro release of the model protein drug, albumin–fluorescein isothiocyanate conjugate (BSA–FITC) from differently composed, photopolymerized poly(ethylene) glycol diacrylate (PEGDA), an often employed, nontoxic, easily curable resin, was investigated. Different PEGDA concentrations in water (20, 30, and 40 wt %) and their different molecular masses (4000, 10,000, and 20,000 g/mol) were used to prepare a protein carrier with photopolymerization and molding. The viscosity measurements of photomonomer solutions revealed exponentially increasing values with increasing PEGDA concentration and molecular mass. Polymerized samples showed increasing medium uptake with an increasing molecular mass and decreasing uptake with increasing PEGDA content. Therefore, the modification of the inner network resulted in the most swollen samples (20 wt %) also releasing the highest amount of incorporated BSA–FITC for all PEGDA molecular masses. |
first_indexed | 2024-03-11T04:38:46Z |
format | Article |
id | doaj.art-e8a097ec961343e48ed7b875a71507aa |
institution | Directory Open Access Journal |
issn | 1999-4923 |
language | English |
last_indexed | 2024-03-11T04:38:46Z |
publishDate | 2023-03-01 |
publisher | MDPI AG |
record_format | Article |
series | Pharmaceutics |
spelling | doaj.art-e8a097ec961343e48ed7b875a71507aa2023-11-17T20:51:50ZengMDPI AGPharmaceutics1999-49232023-03-01154103910.3390/pharmaceutics15041039Influence of PEGDA Molecular Weight and Concentration on the In Vitro Release of the Model Protein BSA–FITC from Photo Crosslinked SystemsNatalia Rekowska0Katharina Wulf1Daniela Koper2Volkmar Senz3Hermann Seitz4Niels Grabow5Michael Teske6Institute for Biomedical Engineering, University Medical Center Rostock, Friedrich-Barnewitz-Straße 4, 18119 Rostock, GermanyInstitute for Biomedical Engineering, University Medical Center Rostock, Friedrich-Barnewitz-Straße 4, 18119 Rostock, GermanyInstitute for Biomedical Engineering, University Medical Center Rostock, Friedrich-Barnewitz-Straße 4, 18119 Rostock, GermanyInstitute for Biomedical Engineering, University Medical Center Rostock, Friedrich-Barnewitz-Straße 4, 18119 Rostock, GermanyMicrofluidics, Faculty of Mechanical Engineering and Marine Technology, University of Rostock, Justus-von-Liebig-Weg 6, 18059 Rostock, GermanyInstitute for Biomedical Engineering, University Medical Center Rostock, Friedrich-Barnewitz-Straße 4, 18119 Rostock, GermanyInstitute for Biomedical Engineering, University Medical Center Rostock, Friedrich-Barnewitz-Straße 4, 18119 Rostock, GermanyNovel 3D printing techniques enable the development of medical devices with drug delivery systems that are tailored to the patient in terms of scaffold shape and the desired pharmaceutically active substance release. Gentle curing methods such as photopolymerization are also relevant for the incorporation of potent and sensitive drugs including proteins. However, retaining the pharmaceutical functions of proteins remains challenging due to the possible crosslinking between the functional groups of proteins, and the used photopolymers such as acrylates. In this work, the in vitro release of the model protein drug, albumin–fluorescein isothiocyanate conjugate (BSA–FITC) from differently composed, photopolymerized poly(ethylene) glycol diacrylate (PEGDA), an often employed, nontoxic, easily curable resin, was investigated. Different PEGDA concentrations in water (20, 30, and 40 wt %) and their different molecular masses (4000, 10,000, and 20,000 g/mol) were used to prepare a protein carrier with photopolymerization and molding. The viscosity measurements of photomonomer solutions revealed exponentially increasing values with increasing PEGDA concentration and molecular mass. Polymerized samples showed increasing medium uptake with an increasing molecular mass and decreasing uptake with increasing PEGDA content. Therefore, the modification of the inner network resulted in the most swollen samples (20 wt %) also releasing the highest amount of incorporated BSA–FITC for all PEGDA molecular masses.https://www.mdpi.com/1999-4923/15/4/1039drug delivery systems3D printingphotopolymerizationPEGDABSA–FITCdrug release |
spellingShingle | Natalia Rekowska Katharina Wulf Daniela Koper Volkmar Senz Hermann Seitz Niels Grabow Michael Teske Influence of PEGDA Molecular Weight and Concentration on the In Vitro Release of the Model Protein BSA–FITC from Photo Crosslinked Systems Pharmaceutics drug delivery systems 3D printing photopolymerization PEGDA BSA–FITC drug release |
title | Influence of PEGDA Molecular Weight and Concentration on the In Vitro Release of the Model Protein BSA–FITC from Photo Crosslinked Systems |
title_full | Influence of PEGDA Molecular Weight and Concentration on the In Vitro Release of the Model Protein BSA–FITC from Photo Crosslinked Systems |
title_fullStr | Influence of PEGDA Molecular Weight and Concentration on the In Vitro Release of the Model Protein BSA–FITC from Photo Crosslinked Systems |
title_full_unstemmed | Influence of PEGDA Molecular Weight and Concentration on the In Vitro Release of the Model Protein BSA–FITC from Photo Crosslinked Systems |
title_short | Influence of PEGDA Molecular Weight and Concentration on the In Vitro Release of the Model Protein BSA–FITC from Photo Crosslinked Systems |
title_sort | influence of pegda molecular weight and concentration on the in vitro release of the model protein bsa fitc from photo crosslinked systems |
topic | drug delivery systems 3D printing photopolymerization PEGDA BSA–FITC drug release |
url | https://www.mdpi.com/1999-4923/15/4/1039 |
work_keys_str_mv | AT nataliarekowska influenceofpegdamolecularweightandconcentrationontheinvitroreleaseofthemodelproteinbsafitcfromphotocrosslinkedsystems AT katharinawulf influenceofpegdamolecularweightandconcentrationontheinvitroreleaseofthemodelproteinbsafitcfromphotocrosslinkedsystems AT danielakoper influenceofpegdamolecularweightandconcentrationontheinvitroreleaseofthemodelproteinbsafitcfromphotocrosslinkedsystems AT volkmarsenz influenceofpegdamolecularweightandconcentrationontheinvitroreleaseofthemodelproteinbsafitcfromphotocrosslinkedsystems AT hermannseitz influenceofpegdamolecularweightandconcentrationontheinvitroreleaseofthemodelproteinbsafitcfromphotocrosslinkedsystems AT nielsgrabow influenceofpegdamolecularweightandconcentrationontheinvitroreleaseofthemodelproteinbsafitcfromphotocrosslinkedsystems AT michaelteske influenceofpegdamolecularweightandconcentrationontheinvitroreleaseofthemodelproteinbsafitcfromphotocrosslinkedsystems |